Incidence, aetiology and epidemiology of uterine fibroids
Tóm tắt
Từ khóa
Tài liệu tham khảo
Buttram, 1986, Uterine leiomyomata – aetiology, symptomatology and management, Prog Clin Biol Res, 225, 275
Marshall, 1997, Variation in the incidence of uterine leiomyoma among premenopausal women by age and race, Obstet Gynecol, 90, 967, 10.1016/S0029-7844(97)00534-6
Day, 2003, High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence, Am J Obstet Gynecol, 188, 100, 10.1067/mob.2003.99
Wise, 2004, Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study, Am J Epidemiol, 159, 113, 10.1093/aje/kwh016
Townsend, 1970, Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase, Am J Obstet Gynecol, 107, 1168, 10.1016/S0002-9378(15)30365-3
Hashimoto, 1995, Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene, Gynecol Obstet Invest, 40, 204, 10.1159/000292336
Burgess, 1989, Epidermal growth factor and transforming growth factor alpha, Br Med Bull, 45, 401, 10.1093/oxfordjournals.bmb.a072331
Reed, 1973, Cutaneous leiomyomata with uterine leiomyomata, Acta Derm Venereol, 53, 409, 10.2340/0001555553409416
Alam, 2001, Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43, Am J Hum Genet, 68, 1264, 10.1086/320124
Alam, 2005, Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer, Br J Dermatol, 153, 11, 10.1111/j.1365-2133.2005.06678.x
Tomlinson, 2002, Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer, Nat Genet, 30, 406, 10.1038/ng849
Vanharanta, 2006, Distinct expression profile in fumarate-hydratase-deficient uterine fibroids, Hum Mol Genet, 15, 97, 10.1093/hmg/ddi431
Kodama, 1996, Profiles of non-cancer diseases in atomic bomb survivors, World Health Stat Q, 49, 7
Kawamura, 1997, Prevalence of uterine myoma detected by ultrasound examination in the atomic bomb survivors, Radiat Res, 147, 753, 10.2307/3579491
Wong, 1993, Noncancer disease incidence in the atomic bomb survivors: 1958–1986, Radiat Res, 135, 418, 10.2307/3578884
Yamada, 2004, Noncancer disease incidence in atomic bomb survivors, 1958–1998, Radiat Res, 161, 622, 10.1667/RR3183
Mashal, 1994, Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata, Genes Chromosomes Cancer, 11, 1, 10.1002/gcc.2870110102
Hennig, 1996, Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps, Mol Hum Reprod, 2, 277, 10.1093/molehr/2.4.277
Hug, 1994, Physical mapping of the uterine leiomyoma t(12; 14)(q13-15; q24.1) breakpoint on chromosome 14 between SPTB and D14S77, Genes Chromosomes Cancer, 11, 263, 10.1002/gcc.2870110409
Ozisik, 1993, Chromosome 7 biclonality in uterine leiomyoma, Cancer Genet Cytogenet, 67, 59, 10.1016/0165-4608(93)90045-N
Sargent, 1994, Translocations in 7q22 define a critical region in uterine leiomyomata, Cancer Genet Cytogenet, 77, 65, 10.1016/0165-4608(94)90151-1
Andersen, 1995, Abnormal gene expression in uterine leiomyomas, J Soc Gynecol Investig, 2, 663, 10.1016/1071-5576(95)00021-6
Brosens, 1998, Clinical significance of cytogenetic abnormalities in uterine myomas, Fertil Steril, 69, 232, 10.1016/S0015-0282(97)00472-X
de Vos, 1994, p53 alterations in uterine leiomyosarcomas versus leiomyomas, Gynecol Oncol, 54, 205, 10.1006/gyno.1994.1194
Zeng, 1997, Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas, Oncogene, 14, 2355, 10.1038/sj.onc.1201076
Kim, 2000, Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium, Am J Reprod Immunol, 43, 53, 10.1111/j.8755-8920.2000.430110.x
Sozen, 1998, Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata, Fertil Steril, 69, 1095, 10.1016/S0015-0282(98)00072-7
Adamson, 1992, Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists, Am J Obstet Gynecol, 166, 746, 10.1016/0002-9378(92)91707-H
Andreyko, 1987, Therapeutic uses of gonadotropin-releasing hormone analogs, Obstet Gynecol Surv, 42, 1, 10.1097/00006254-198701000-00001
Friedman, 1990, Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis, Am J Obstet Gynecol, 163, 1114, 10.1016/0002-9378(90)90667-V
Kawaguchi, 1989, Mitotic activity in uterine leiomyomas during the menstrual cycle, Am J Obstet Gynecol, 160, 637, 10.1016/S0002-9378(89)80046-8
Brandon, 1995, Estrogen receptor gene expression in human uterine leiomyomata, J Clin Endocrinol Metab, 80, 1876, 10.1210/jc.80.6.1876
Andersen, 1995, Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures, J Soc Gynecol Investig, 2, 542, 10.1016/1071-5576(94)00053-4
Pollow, 1978, Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue, J Clin Chem Clin Biochem, 16, 503
Howe, 1995, Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines, Am J Pathol, 146, 1568
Howe, 1995, Estrogen/antiestrogen responsiveness in an in vivo/in vitro model for myometrial tumorigenesis, Ann N Y Acad Sci, 761, 373, 10.1111/j.1749-6632.1995.tb31396.x
Burroughs, 2000, Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat, Biol Reprod, 63, 1322, 10.1095/biolreprod63.5.1322
Hunter, 1999, Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium, Cancer Res, 59, 3090
Hunter, 2000, Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids, Environ Health Perspect, 108, 829, 10.1289/ehp.00108s5829
Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta, Endocrinology, 138, 863, 10.1210/en.138.3.863
Fotsis, 1993, Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc Natl Acad Sci U S A, 90, 2690, 10.1073/pnas.90.7.2690
Kawaguchi, 1991, Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy, Virchows Arch A Pathol Anat Histopathol, 419, 309, 10.1007/BF01606522
Tiltman, 1985, The effect of progestins on the mitotic activity of uterine fibromyomas, Int J Gynecol Pathol, 4, 89, 10.1097/00004347-198506000-00001
Brandon, 1993, Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas, Am J Obstet Gynecol, 169, 78, 10.1016/0002-9378(93)90135-6
Shimomura, 1998, Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma, J Clin Endocrinol Metab, 83, 2192, 10.1210/jc.83.6.2192
Matsuo, 1999, Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma, Oncology, 57, 49, 10.1159/000055275
Hyder, 1999, Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins, Mol Endocrinol, 13, 806, 10.1210/me.13.6.806
Dixon, 2000, Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium, Environ Health Perspect, 108, 795, 10.1289/ehp.00108s5795
Gentry, 2001, Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium, Clin Sci (Lond), 101, 691, 10.1042/CS20010096
Giudice, 1993, Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata, Hum Reprod, 8, 1796, 10.1093/oxfordjournals.humrep.a137937
Sharara, 1995, Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium, Am J Obstet Gynecol, 173, 814, 10.1016/0002-9378(95)90346-1
Cohick, 1993, Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors, J Cell Physiol, 157, 52, 10.1002/jcp.1041570107
Burroughs, 2002, Dysregulation of IGF-I signaling in uterine leiomyoma, J Endocrinol, 172, 83, 10.1677/joe.0.1720083
Nicosia, 1999, Autoregulation of angiogenesis by cells of the vessel wall, Int Rev Cytol, 185, 1, 10.1016/S0074-7696(08)60148-5
Shing, 1984, Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor, Science, 223, 1296, 10.1126/science.6199844
Goto, 1993, Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels, Lab Invest, 69, 508
Tsai, 1995, Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF, J Neurosurg, 82, 864, 10.3171/jns.1995.82.5.0864
Mangrulkar, 1995, Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium, Biol Reprod, 53, 636, 10.1095/biolreprod53.3.636
Anania, 1997, Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding, Mol Hum Reprod, 3, 685, 10.1093/molehr/3.8.685
Rauk, 1995, Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells, Am J Obstet Gynecol, 173, 571, 10.1016/0002-9378(95)90284-8
Palman, 1992, Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors, Lab Invest, 66, 108
Boehm, 1990, Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues, Mol Reprod Dev, 27, 93, 10.1002/mrd.1080270203
Ross, 1986, The biology of platelet-derived growth factor, Cell, 46, 155, 10.1016/0092-8674(86)90733-6
Arici, 2003, Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma, Am J Obstet Gynecol, 188, 76, 10.1067/mob.2003.118
Fayed, 1989, Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin, Lab Invest, 60, 30
Barbarisi, 2001, 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway, J Cell Physiol, 186, 414, 10.1002/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E
Harrison-Woolrych, 1995, Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata, J Clin Endocrinol Metab, 80, 1853, 10.1210/jc.80.6.1853
Hofmann, 1984, Binding sites for epidermal growth factor in human uterine tissues and leiomyomas, J Clin Endocrinol Metab, 58, 880, 10.1210/jcem-58-5-880
Vollenhoven, 1995, Epidermal growth factor and transforming growth factor-beta in uterine fibroids and myometrium, Gynecol Obstet Invest, 40, 120, 10.1159/000292319
Tommola, 1989, Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata, Obstet Gynecol, 74, 658
Moore, 2000, Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice, Exp Toxicol Pathol, 52, 195, 10.1016/S0940-2993(00)80028-7
Rosenthal, 1986, Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation, Cell, 46, 301, 10.1016/0092-8674(86)90747-6
Leppert, 2006, A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays, Am J Obstet Gynecol, 195, 415, 10.1016/j.ajog.2005.12.059
Arici, 2000, Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation, Fertil Steril, 73, 1006, 10.1016/S0015-0282(00)00418-0
Lee, 2001, Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta, J Clin Endocrinol Metab, 86, 913, 10.1210/jc.86.2.913
Luo, 2005, Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta, Endocrinology, 146, 1097, 10.1210/en.2004-1377
Politi, 2004, A mouse model of uterine leiomyosarcoma, Am J Pathol, 164, 325, 10.1016/S0002-9440(10)63122-7
Dvorak, 1995, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am J Pathol, 146, 1029
Ferrara, 1999, Vascular endothelial growth factor: molecular and biological aspects, Curr Top Microbiol Immunol, 237, 1, 10.1007/978-3-642-59953-8_1
Hyder, 1998, Progestin regulation of vascular endothelial growth factor in human breast cancer cells, Cancer Res, 58, 392
Brown, 1997, Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor, Lab Invest, 76, 245
Charnock-Jones, 1993, Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines, Biol Reprod, 48, 1120, 10.1095/biolreprod48.5.1120
Gleeson, 1994, Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia, Am J Obstet Gynecol, 171, 178, 10.1016/0002-9378(94)90466-9
Hyder, 1997, Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780, Cancer Res, 57, 2547
Hyder, 1999, Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol, J Pharmacol Exp Ther, 290, 740
Hyder, 2000, Regulation of vascular endothelial growth factor expression by estrogens and progestins, Environ Health Perspect, 108, 785, 10.1289/ehp.00108s5785
Ruohola, 1999, Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells, Mol Cell Endocrinol, 149, 29, 10.1016/S0303-7207(99)00003-9
Shifren, 1996, Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis, J Clin Endocrinol Metab, 81, 3112, 10.1210/jc.81.8.3112
Folkman, 1971, Isolation of a tumor factor responsible for angiogenesis, J Exp Med, 133, 275, 10.1084/jem.133.2.275
Mustonen, 1995, Endothelial receptor tyrosine kinases involved in angiogenesis, J Cell Biol, 129, 895, 10.1083/jcb.129.4.895
Freitas, 1992, Tumor angiogenesis: evidence of new blood channels from plasma infiltrations, Experientia Suppl, 61, 81, 10.1007/978-3-0348-7001-6_14
Good, 1990, A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin, Proc Natl Acad Sci U S A, 87, 6624, 10.1073/pnas.87.17.6624
Wang, 2002, Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells, Eur J Endocrinol, 146, 447, 10.1530/eje.0.1460447
Matsuo, 1997, Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone, J Clin Endocrinol Metab, 82, 293, 10.1210/jc.82.1.293
Wu, 2002, Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause, J Steroid Biochem Mol Biol, 80, 77, 10.1016/S0960-0760(01)00177-7
Kurachi, 2001, Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone, J Clin Endocrinol Metab, 86, 2275, 10.1210/jc.86.5.2275
Haviv, 1999, Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells, J Neurosci Res, 55, 269, 10.1002/(SICI)1097-4547(19990201)55:3<269::AID-JNR1>3.0.CO;2-3
Gao, 2002, p53 Tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17 beta-estradiol, J Clin Endocrinol Metab, 87, 3915, 10.1210/jc.87.8.3915
Baek, 2003, Increased expression of cyclin G1 in leiomyoma compared with normal myometrium, Am J Obstet Gynecol, 188, 634, 10.1067/mob.2003.140
Kjerulff, 1996, Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis, J Reprod Med, 41, 483
Okolo, 2005, Familial prevalence of uterine fibroids is associated with distinct clinical and molecular features, Hum Reprod, 20, 2321, 10.1093/humrep/dei049
Al Hendy, 2006, Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans, Fertil Steril, 86, 686, 10.1016/j.fertnstert.2006.01.052
Pan, 2007, Genomic and proteomic profiling I: leiomyomas in African Americans and Caucasians, Reprod Biol Endocrinol, 5, 34, 10.1186/1477-7827-5-34
Amant, 2003, Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels, J Soc Gynecol Investig, 10, 105, 10.1016/S1071-5576(02)00253-8
Wei, 2006, Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata, Hum Reprod, 21, 57, 10.1093/humrep/dei309
Gross, 2001, Genetics and the development of fibroids, Clin Obstet Gynecol, 44, 335, 10.1097/00003081-200106000-00020
Kurbanova, 1989, Genetic analysis of the predisposition to uterine myoma. Prevalence and morbidity, Genetika, 25, 1122
Kurbanova, 1989, Genetic-epidemiologic analysis of uterine myoma: assessment of repeated risk, Genetika, 25, 1896
Vikhlyaeva, 1995, Familial predisposition to uterine leiomyomas, Int J Gynaecol Obstet, 51, 127, 10.1016/0020-7292(95)02533-I
Luoto, 2000, Heritability and risk factors of uterine fibroids – the Finnish Twin Cohort study, Maturitas, 37, 15, 10.1016/S0378-5122(00)00160-2
Treloar, 1992, Pathways to hysterectomy: insights from longitudinal twin research, Am J Obstet Gynecol, 167, 82, 10.1016/S0002-9378(11)91632-9
Snieder, 1998, Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause, J Clin Endocrinol Metab, 83, 1875, 10.1210/jc.83.6.1875
Zotalis, 1998, Leiomyomatosis peritonealis disseminata, endometriosis, and multicystic mesothelioma: an unusual association, Int J Gynecol Pathol, 17, 178, 10.1097/00004347-199804000-00015
Chiaffarino, 1999, Use of oral contraceptives and uterine fibroids: results from a case–control study, Br J Obstet Gynaecol, 106, 857, 10.1111/j.1471-0528.1999.tb08409.x
Faerstein, 2001, Risk factors for uterine leiomyoma: a practice-based case–control study. I. African-American heritage, reproductive history, body size, and smoking, Am J Epidemiol, 153, 1, 10.1093/aje/153.1.1
Lumbiganon, 1996, Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case–control study, Br J Obstet Gynaecol, 103, 909, 10.1111/j.1471-0528.1996.tb09911.x
Marshall, 1998, A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata, Fertil Steril, 70, 432, 10.1016/S0015-0282(98)00208-8
Parazzini, 1988, Epidemiologic characteristics of women with uterine fibroids: a case–control study, Obstet Gynecol, 72, 853, 10.1097/00006250-198812000-00008
Parazzini, 1996, Reproductive factors and risk of uterine fibroids, Epidemiology, 7, 440, 10.1097/00001648-199607000-00018
Ross, 1986, Risk factors for uterine fibroids: reduced risk associated with oral contraceptives, Br Med J (Clin Res Ed), 293, 359, 10.1136/bmj.293.6543.359
Samadi, 1996, Risk factors for self-reported uterine fibroids: a case–control study, Am J Public Health, 86, 858, 10.2105/AJPH.86.6.858
Chen, 2001, Risk factors for uterine fibroids among women undergoing tubal sterilization, Am J Epidemiol, 153, 20, 10.1093/aje/153.1.20
Spellacy, 1972, Plasma growth hormone and estradiol levels in women with uterine myomas, Obstet Gynecol, 40, 829
Baird, 2006, Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development, J Soc Gynecol Investig, 13, 130, 10.1016/j.jsgi.2005.12.001
Shemesh, 2001, Actions of gonadotrophins on the uterus, Reproduction, 121, 835, 10.1530/rep.0.1210835
Stewart, 2001, Gonadotropins and the uterus: is there a gonad-independent pathway?, J Soc Gynecol Investig, 8, 319, 10.1016/S1071-5576(01)00136-8
Tesarik, 2003, Luteinizing hormone affects uterine receptivity independently of ovarian function, Reprod Biomed Online, 7, 59, 10.1016/S1472-6483(10)61729-4
Wise, 2007, Polycystic ovary syndrome and risk of uterine leiomyomata, Fertil Steril, 87, 1108, 10.1016/j.fertnstert.2006.11.012
Hammoud, 2006, Volume change of uterine myomas during pregnancy: do myomas really grow?, J Minim Invas Gynecol, 13, 386, 10.1016/j.jmig.2006.04.003
Cooper, 2005, Fibroids in pregnancy – common but poorly understood, Obstet Gynecol Surv, 60, 132, 10.1097/01.ogx.0000154688.02423.68
Neiger, 2006, Pregnancy-related changes in the size of uterine leiomyomas, J Reprod Med, 51, 671
Cesen-Cummings, 2000, Pregnancy, parturition, and prostaglandins: defining uterine leiomyomas, Environ Health Perspect, 108, 817, 10.1289/ehp.00108s5817
Cesen-Cummings, 2003, Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling, J Soc Gynecol Investig, 10, 11, 10.1016/S1071-5576(02)00191-0
Musey, 1987, Age-related changes in the female hormonal environment during reproductive life, Am J Obstet Gynecol, 157, 312, 10.1016/S0002-9378(87)80159-X
Musey, 1987, Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens, J Clin Endocrinol Metab, 64, 111, 10.1210/jcem-64-1-111
Musey, 1987, Long-term effect of a first pregnancy on the secretion of prolactin, N Engl J Med, 316, 229, 10.1056/NEJM198701293160501
Walker, 2001, Protective effect of pregnancy for development of uterine leiomyoma, Carcinogenesis, 22, 2049, 10.1093/carcin/22.12.2049
Chiaffarino, 1998, Oral contraceptive use and benign gynecologic conditions. A review, Contraception, 57, 11, 10.1016/S0010-7824(97)00201-1
Friedman, 1995, Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?, Obstet Gynecol, 85, 631, 10.1016/0029-7844(95)00007-E
Magalhaes, 2007, Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas, Contraception, 75, 193, 10.1016/j.contraception.2006.11.004
Shikora, 1991, Relationship between obesity and uterine leiomyomata, Nutrition, 7, 251
Summers, 1971, Hypertension, obesity, and fibromyomata uteri, as a syndrome, Arch Intern Med, 128, 750, 10.1001/archinte.128.5.750
Wise, 2005, Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women, Epidemiology, 16, 346, 10.1097/01.ede.0000158742.11877.99
Faerstein, 2001, Risk factors for uterine leiomyoma: a practice-based case–control study. II. Atherogenic risk factors and potential sources of uterine irritation, Am J Epidemiol, 153, 11, 10.1093/aje/153.1.11
Baron, 1988, Cigarette smoking and other correlates of cytologic estrogen effect in postmenopausal women, Fertil Steril, 50, 766, 10.1016/S0015-0282(16)60313-8
Marshall, 1998, Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking, Epidemiology, 9, 511, 10.1097/00001648-199809000-00007
Wise, 2004, Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study, Hum Reprod, 19, 1746, 10.1093/humrep/deh309
Parazzini, 1996, Uterine myomas and smoking. Results from an Italian study, J Reprod Med, 41, 316